Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Crawley

Showing results (21-30 of 208) with videos related to

Pageof 21
Sort By:
Brain Research|November 15, 1988
Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbensJ N Crawley
Brain Research|August 17, 1999
Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral testsJ N Crawley
Neuropeptides|February 5, 2000
The role of galanin in feeding behaviorJ N Crawley
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1992
Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathwayJ N Crawley
Pharmacology, Biochemistry, and Behavior|November 1, 1981
Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepinesJ N Crawley
Psychopharmacology Bulletin|January 1, 1985
Cholecystokinin potentiates dopamine-mediated behaviors in the nucleus accumbens, a site of CCK-DA co-existenceJ N Crawley
Annals of the New York Academy of Sciences|January 1, 1988
Modulation of mesolimbic dopaminergic behaviors by cholecystokininJ N Crawley
Peptides|January 1, 1985
Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide poolsJ N Crawley
European Journal of Pharmacology|August 24, 1988
Behavioral evidence for increased acetylcholine receptor sensitivity after nucleus basalis magnocellularis lesions in the ratJ Mastropaolo, J N Crawley
Life Sciences|January 1, 1988
Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokininS Khosla, J N Crawley
Pageof 21

Showing results (21-30 of 208) with videos related to

Sort By:
Pageof 21
Brain Research|November 15, 1988
Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbensJ N Crawley
Brain Research|August 17, 1999
Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral testsJ N Crawley
Neuropeptides|February 5, 2000
The role of galanin in feeding behaviorJ N Crawley
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1992
Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathwayJ N Crawley
Pharmacology, Biochemistry, and Behavior|November 1, 1981
Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepinesJ N Crawley
Psychopharmacology Bulletin|January 1, 1985
Cholecystokinin potentiates dopamine-mediated behaviors in the nucleus accumbens, a site of CCK-DA co-existenceJ N Crawley
Annals of the New York Academy of Sciences|January 1, 1988
Modulation of mesolimbic dopaminergic behaviors by cholecystokininJ N Crawley
Peptides|January 1, 1985
Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide poolsJ N Crawley
European Journal of Pharmacology|August 24, 1988
Behavioral evidence for increased acetylcholine receptor sensitivity after nucleus basalis magnocellularis lesions in the ratJ Mastropaolo, J N Crawley
Life Sciences|January 1, 1988
Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokininS Khosla, J N Crawley
Pageof 21